Wınalıte Internatıonal is a multinational corporation specializing in the research, development, manufacturing and marketing of high-tech products. With its major product “Love Moon” Anion Sanitary Napkin, it has received positive responses from the global market as well as wide recognition and a stellar reputation since its founding in January 2007. As its scale of operation and market demand has grown, WINALITE has gradually developed a diversified global product strategy and launched various high-tech healthcare products into overseas markets. The company currently owns three modernized plants, whose standard factory buildings cover a total area of 100,000 square meters. They provide WINALITE a solid basis from which to meet ever-growing customer demands and also provide support for its global expansion to overseas market.
At present time, WINALITE has more than 1,000 employees across the world, including many senior level management personnel with extensive experience in managing multinational corporations. More than five million global distributors have helped WINALITE expand its market into 78 countries and regions throughout the world, developing a global organizational strategy and a large-scale management mode in which the global headquarters coordinates its ten operation regions, including Greater Russia, Greater India, Southeast Asia, Northeast Asia, Europe, Africa, North America, South America, Oceania and the Middle East.
Under the guidance of its corporate philosophy, “Passion, Commitment, Contribution, Win-win, Innovation” and its corporate culture, “Boundless Love, All for Love”, WINALITE is striding firmly towards a promising global market.
Contact Details
Istanbul Office:
Buyukdere St. Liquor Side Street Business center of Akabe C/1 – Sisli/Istanbul
T. +90 212 217 57 58 – 217 73 75
Fax: +90 212 217 73 78
Consumer healthcare products manufacturer Winalite is working to penetrate the Turkish market, but with regulations complicating bringing their portfolio from China, general manager Arafat Yadigar is looking to develop a…
Consumer healthcare products manufacturer Winalite is working to penetrate the Turkish market, but with regulations complicating bringing their portfolio from China, general manager Arafat Yadigar is looking to develop a…
Ozgur Tomruk, J&J’s Managing Director for Global Surgery talks about Turkey’s importance for the company, the priorities they have set, J&J’s commitment to quality and his ambition for the company’s…
Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s technology overhaul, and also highlights the type of logistics solutions encompassed under Transorient’s…
Matthias Diewald (MD) and Asli Volkan (AV) elaborate on HELM Kimya’s longstanding presence within Turkey and the type of market opportunities available for co-development and contract manufacturing. They also explain the…
Haluk Ataoglu, academic turned founder of Matriks Biotek®, talks about his aspirations for his company and the Turkish R&D landscape as well as how to penetrate the global pharmaceutical market…
Prof. Dr. Murat Özgören, the architect behind the ambitious BioIzmir project, talks about its potential and how it intends to educate new talent to address critical future needs of the…
BMS Turkey’s new general manager discusses Opdivo (nivolumab) their revolutionary new product for squamous non-small cell lung cancer, their registry of 1200 patients in Turkey with melanoma, potential developments in pharmaceutical…
Multinational R&D investment in Turkey, particularly investment in clinical trials, has been quite limited relative to the size of the Turkish pharmaceutical market. Turkish R&D spending amounted to just 0.95…
Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in Turkey are constructed from the lowest price in…
In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation: that’s the core message Minister of Health Mehmet Müezzinoğlu gave PharmaBoardroom. This is the beginning…
Recep Altekin, the general manager of MT Sağlik – market leader in Turkey for blood glucose monitoring systems and diabetes test strips by volume – tells PharmaBoardroom about his company’s impact…
AstraZeneca’s Country President for Turkey discusses their efforts to build scientific leadership in Turkey in line with their global strategy and her hopes for the market access and public-private partnership…
See our Cookie Privacy Policy Here
